Report Overview

The EU Pain Management Devices market is proliferating at a 7.9% CAGR through 2019-2028. The market currently stood at USD XX billion in 2019 and expected to reach USD XX billion in 2028

Chronic pain is a distressing problem, which has a significant impact on society and individuals. It mainly presents as a result of an injury or a disease; however, it is a separate condition in its own right, not merely an accompanying symptom of other ailments. The incidence of chronic pain increases the dependency of a person on others for various daily tasks. Therefore, pain management is an essential step to carry out a regular daily routine. Pain management devices provide relief for longer durations and also improve their health. A wearable pain management device is easy to use and operate and it reduces the persons dependency on others. Owing to such advantages of pain management devices, their demand is rising among patients with chronic diseases. Among the EU countries, Chronic pain is a severe health problem in Spain. As per a research study published, 23.4% of the Spanish population suffers from chronic pain. Chronic pain is also prevalent among cancer patients, ranging from 33% to 64% according to the disease stage



Market Growth Drivers

The increasing geriatric population, growth in the diabetic population suffering from pain, technological advancements, are majorly driving the market growth. Additionally, high income and standard growth in joint and chronic acute illnesses are further fueling the market. Favorable reimbursement policies and growing R&D to develop new products are other significant factors to bolster the EU market. The high cost of the devices, fewer knowledge levels about these products may hamper the EU Pain Management Device market